Clinical Report: Exploring the Role of Social Genomics in SCCa Outcomes
Overview
This review examines how social determinants of health (SDoH) influence outcomes in squamous cell carcinomas (SCCa) through biological mechanisms. It highlights the role of socioeconomic conditions and epigenetic modifications in shaping cancer outcomes.
Background
Understanding the impact of social determinants on cancer outcomes is crucial, as disparities in access to care and treatment can lead to worse survival rates in socioeconomically disadvantaged populations. SCCa, particularly in the head and neck, esophagus, and lungs, serves as a relevant model for studying these disparities due to its association with environmental exposures and socioeconomic gradients.
Data Highlights
No numerical data provided in the article.
Key Findings
Adverse socioeconomic conditions, such as neighborhood deprivation, are linked to poorer SCCa outcomes.
The activation of the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system contributes to dysregulated immune signaling in SCCa.
Distinct race- and neighborhood-specific DNA methylation patterns have been observed in SCCa.
Therapeutic strategies targeting biological mediators, including β-adrenergic blockers and DNA methyltransferase inhibitors, show variable efficacy in SCCa models.
Incorporating social context into genomic analysis may help identify population-level cancer risk patterns.
Clinical Implications
Healthcare professionals should consider the influence of social determinants on cancer outcomes when developing treatment plans. Understanding the biological mechanisms linking socioeconomic factors to tumor biology may inform personalized approaches to cancer prevention and treatment.
Conclusion
Social genomics offers insights into how socio-environmental factors interact with tumor biology, potentially influencing disparities in SCCa outcomes. Future research should focus on integrating geospatial and multi-omics data for improved cancer management.
